Comparative Bioavailability and Bioequivalence of Oxazepam 10 mg Orodispersible Tablets (Test) Versus Seresta® 10 mg Tablets (Reference): A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, Two-Period Crossover Study in Healthy Subjects
CompletedCTIS2022-501134-35-00
Laboratorios Lesvi S.L.No medical condition is being investigated. This is a comparative bioavailabilty study.
Start: 2022-10-26End: 2022-11-13Target: 28Updated: 2022-10-24